Factors Responsible for Coverage and Compliance in Mass Drug Administration during the Programme to Eliminate Lymphatic Filariasis in the East Godavari District,South India
Restricted accessResearch articleFirst published online April, 2003
Factors Responsible for Coverage and Compliance in Mass Drug Administration during the Programme to Eliminate Lymphatic Filariasis in the East Godavari District,South India
The paper attempts to report the factors responsible for the coverage and compliance of mass diethylcarbamazine citrate (DEC) administration, during the programme to eliminate lymphatic filariasis in the East Godavari District of Andhra Pradesh, India. The evaluation survey indicates that single dose DEC was received by 77% and taken by 64% of eligible people. Reasons for non-reception and non-consumption of the drug at household level were identified. The factors that influenced the coverage and compliance of treatment are broadly categorized as health services related, community related and drug related factors. The study identified some key factors to be followed for the success of the programme.
Get full access to this article
View all access options for this article.
References
1.
RamaiahKDDasPKMichaelEGuyattH. The economic burden of lymphatic filariasis in India. Parasitol Today2000;16:251–3.
2.
National Filariasis Control Programme. Revised Strategy for Filariasis Control in India: A Pilot Project. New Delhi: National Malaria Eradication Programme, 1998.
3.
OttesenEADukeBOLKaramMBehbehaniK. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ1997;75:491–503.
4.
Filariasis Research and Training Centre. Pre-Control Filarial Morbidity Assessment. Kakinada: Filariasis Research and Training Centre (Government of Andhra Pradesh), 1998.
5.
KhanMEAnkerMPatelBCBargeSSadhwaniHKohleR. The use of focus groups in social and behavioural research: some methodological issues. World Health Stat Q1991;44:145–9.
6.
HudelsonPM. Qualitative Research for Health Programmes, Document No. WHO/MNH/PSF/94.3. Geneva: World Health Organization, 1994.
7.
PeltoJPPeltoGH. Anthropological Research: The Structure of Inquiry. Cambridge: Cambridge University Press, 1978.
8.
SommerlundB. TextBase Beta User's Manual. Risskov: University of Aarhus, 1995.
9.
World Health Organization. Report from Informal Consultation on Albendazole Research Findings in Lymphatic Filariasis. Document No. WHO/FIL/98.194. Geneva: World Health Organization, 1998.
10.
RamaiahKDDasPKAppavooNCA programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health2000;5:842–7.
11.
ManiTRRajendranRMunirathinamAEfficacy of co-administration of albendazole and diethylcarbamazine on geohelminthiases: a study from South India. Trop Med Int Health2002;7:541–8.
